EL7.AI
StocksMediumUpdated×3•Originally published 30 July 2026•Updated 30 July 2026•
1 min read

Earnings Roundup: Hershey and Air Products Beat Estimates as Neogen Surges 10%

Key Facts

1Hershey narrowed its 2026 sales and adjusted earnings outlook to the upper half of its previous ranges.
2Lloyds Banking Group reported first-half statutory profit after tax of £3.1 billion.
3Teladoc Health reduced its full-year revenue outlook due to lower cash-pay revenue at BetterHelp.

Amidst a wave of quarterly reports reflecting corporate resilience, several major players in the consumer and industrial sectors have delivered earnings beats. Hershey reported adjusted EPS of $1.90 for Q2 2026, surpassing analyst estimates, while Neogen shares surged 10.43% following a fiscal fourth-quarter beat. In the industrial space, Air Products raised its full-year EPS growth guidance to 11%-12% after posting Q3 fiscal EPS of $3.47, signaling strong operational momentum.

Strategic partnerships are driving long-term sentiment, highlighted by Air Products' new marketing and distribution deal with Yara for renewable ammonia sourced from the NEOM Green Hydrogen Project. Per market data, this corporate strength contrasts with steady performance elsewhere, as Lloyds Banking Group (LYG) closed at $6.01 and Takeda Pharmaceutical (TAK) at $17.52 on July 28, 2026, illustrating a divergence between high-growth industrial catalysts and stable financial peers.

As of the close on July 28, 2026, Hershey (HSY) stood at $183.39 following its guidance update. Investors are now shifting focus to the execution of the NEOM partnership as a primary catalyst for Air Products, while broader market sentiment remains cautious following the Chicago Fed National Activity Index print of -0.02, which suggests a cooling macroeconomic environment for manufacturing and consumer staples.